Perfect Healthcare (01830)'s overall annual sales are expected to be no less than HK$1.4 billion, a year-on-year decrease of no more than 0.5%
Perfect Healthcare (01830) issued an announcement. The Group expects that the overall sales volume for the year ending March 31, 2024 will not be...
Perfect Medical Anticipates Sales Contracts to Drop Marginally in 12 Months to March
Perfect Medical Health Management (HKG:1830) anticipates overall sales contracts of at least HK$1.4 billion for the fiscal year ended March 31, 2024, down 0.5% from a year ago, according to a filing w
Featured announcements | Ideal Auto's Q1 net profit fell by more than 30%; Ctrip's Q1 net profit increased 28% year over year
China Resources Power's PV sales nearly tripled during the year; Tencent spent about HK$1.04 billion to buy back 2.54 million shares.
The market is picking up, and listed companies are pouring in medical and aesthetic institutions. Who will win the next “C-rank material”?
Catalyzed by various factors, the medical and aesthetic market recovered to a certain extent in the first quarter, while the performance of listed companies, whether midstream medical and aesthetic institutions or upstream producers, has steadily improved since this year.
Changes in Hong Kong stocks | Perfect Healthcare (01830) fell by more than 4%, and its stock price fell by more than 26% in a month. The market expects poor operating performance in the first quarter
The Zhitong Finance App learned that Perfect Healthcare (01830) fell by more than 4%, and the stock has already declined by more than 26% during the month. As of press release, it decreased by 4.08% to HK$2.35, with a turnover of HK$2,513,200. According to the news, Galaxy International recently reported that the target price for Perfect Care was lowered by 40.8%, from HK$7.4 to HK$4.38. The bank believes that Perfect Healthcare's stock price fell by more than 20% in the last 10 trading days, mainly because the market expects poor operating performance in the first quarter of 2024. The company's revenue growth from Hong Kong operations in the fourth quarter of 2023 is expected in units, but due to Hong Kong people
Express News | General Administration of Market Regulation: Maintain a high-pressure crackdown on illegal acts of medical and aesthetic advertising and strictly regulate the publication of medical and aesthetic advertisements
Express News | Fangzheng Securities: The cosmetics, medical and aesthetic industries are expected to usher in strong breakthroughs
The Little Peak of Medicine and Aesthetics is here! There was a wave of beauty concentrated before the Spring Festival, but why did the practitioners continue to complain? |Industry Watch
Ultrasound cannons are booked three days in advance, and the administration is transferred to the front desk to receive customers... A Financial Association reporter recently visited several medical and aesthetic institutions in Chengdu and found that as the Spring Festival approaches, there has been a marked increase in the number of consumers visiting hospitals for consultation and treatment, and some popular programs require advance reservations.
Medical and aesthetic recovery stalled in the second half of the year, triggering a price war. Listed companies target a new “optoelectronic anti-aging” track|year-end inventory
Financial Services Association, December 26 (Reporter He Fan) As the end of the year progresses, the medical and aesthetic market does not seem to be “in full swing” as predicted at the beginning of the year.
Perfect Healthcare (01830.HK) granted 3.768 million share options
Glonghui December 12 | Perfect Healthcare (01830.HK) announced that on December 12, 2023, the company has granted 3.768 million share options to the company's eligible employees according to the share option plan adopted on August 13, 2021. The exercise price of the share options is HK$3.346 per share, and the closing price of the company's shares on the date of grant is HK$3.320 per share.
Perfect Healthcare (1830.HK): Performance meets expectations, stores expand steadily
Incident: November 24, 2023, the company announced FY2024 interim results. From April 1, 2023 to September 30, 2023, the company achieved operating income of HK$718 million (+7.5)
完美醫療:中期報告 2023/2024
Announcement Selection: Huazhu Group's Q3 revenue increased by more than 50% year on year; China's Jinmao plans to spend nearly 1.9 billion yuan to acquire shares in real estate projects
Colon Botai Bio-B: The main product, A400 (EP0031), was granted orphan drug qualification by the US Food and Drug Administration; Anta Sports: Proposed purchase of shares under a share incentive plan, with a total investment of no more than HK$1.2 billion.
PERFECT MEDICAL To Go Ex-Dividend On December 7th, 2023 With 0.132 HKD Dividend Per Share And 0.01 HKD Special Dividend Per Share
November 25th - $PERFECT MEDICAL(01830.HK)$ is trading ex-dividend on December 7th, 2023. Shareholders of record on December 8th, 2023 will receive 0.132 HKD dividend per share and 0.01 HKD specia
Perfect Medical Health Management's Profit Climbs 10.4% in Fiscal H1
Perfect Medical Health Management (HKG:1830) recorded a profit attributable to owners of HK$166.4 million for the fiscal first half, up 10.4% from HK$150.7 million a year ago. Earnings per share rose
Perfect Healthcare (01830.HK)'s net profit after tax increased 10.4% in the medium term to HK$166 million
Gelonghui November 24 | Perfect Healthcare (01830.HK) announced that in the six months ended September 30, 2023, the company's revenue increased 7.5% to HK$718.1 million; net profit after tax increased by 10.4% to HK$166.4 million. Excluding Hong Kong government subsidies, the revised net profit after tax increased by 27.1%. Basic earnings per share increased 9.1% to HK13.2 cents. The proposed interim dividend and special dividend are HK13.2 cents and 1.0 HK cents per share, with a total dividend of HK14.2 cents per share and a dividend rate of 107.6%.
PERFECT MEDICAL: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Perfect Healthcare (01830.HK) will hold a board meeting on November 24 to approve the interim results
Gelonghui November 14 | Perfect Healthcare (01830.HK) announced that the company will hold a board meeting on November 24, 2023 to approve and publish the interim results of the company and its subsidiaries for the six months ended September 30, 2023, and consider the payment of interim dividends (if any).
PERFECT MEDICAL: DATE OF BOARD MEETING
PERFECT MEDICAL: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2023 ANNUAL REPORT
No Data